Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

Joerg Ermann, MD  |  Issue: July 2016  |  July 13, 2016

Figure 3: Prevalence of HLA-B27 in Indigenous Populations (%) Source: Data adapted from Khan14

(click for larger image)
Figure 3: Prevalence of HLA-B27 in Indigenous Populations (%)

Source: Data adapted from Khan14

These patterns reflect two major influences that have shaped MHC profiles in populations: migration and natural selection. For example, HLA-B27 is absent in the indigenous populations of South America, and the HLA-B27 alleles prevalent on this continent today represent genetic admixture from Europe and Africa.15 It has been argued that the lack of HLA-B27 in South America and Southern Africa and the high frequency of HLA-B*27:06 in Southeast Asia may be the result of selective pressure by malaria or other infectious diseases.16 On the other hand, there is evidence that HLA-B27 is associated with HIV elite controller status and higher virus clearance rates after acute HCV infection.17 Thus, being HLA-B27 positive may be a selective advantage in certain circumstances, which might explain the high prevalence in circumpolar regions.

Figure 4: HLA Subtypes Source: Data adapted from Mathieu et al54

(click for larger image)
Figure 4: HLA Subtypes

Source: Data adapted from Mathieu et al54

The 2009 NHANES (National Health and Nutrition Examination Survey) study examined the prevalence of axial SpA and HLA-B27 in subjects representative of the U.S. population. Interestingly, HLA-B27 was significantly less frequent in the older age brackets (3.6% in 50–69-year-olds vs. 7.3% in 20–49-year-olds).18 This difference remained statistically significant after adjusting for sex and race/ethnicity, suggesting that HLA-B27 positivity might be associated with early mortality (e.g., via effects on atherosclerosis or cancer), a surprising finding that needs to be confirmed in an independent cohort.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

HLA-B27 Transgenic Animals

The debate whether HLA-B27 itself plays a role in the pathogenesis of AS or whether it is simply a genetic marker for another closely linked genetic variant that drives the disease has by now been settled. One important piece of evidence for the direct role of the HLA-B27 molecule was the demonstration that rats transgenic for HLA-B*27:05 and human b2m developed a SpA-like syndrome.19 The disease in HLA-B27 transgenic rats is characterized by colitis and diarrhea, an erosive arthritis affecting peripheral and axial joints, psoriasis-like hyperkeratotic skin lesions and nail dystrophy, as well as orchitis and epididymitis. Some of the phenotypes are strongly microbiota dependent, because germfree rats do not develop arthritis and colitis, but they do develop epididymitis and skin inflammation. Colonization of germfree animals with commensal bacteria reestablished colitis and arthritis.20 Disease could be transferred by transplantation of transgenic bone marrow into non-transgenic recipients, mapping the function of the HLA-B27 transgene to hematopoietically derived cells. However, contrary to expectations based on the canonical function of MHC class I molecules, it has conclusively been shown that CD8+ T cells are dispensable for the development of disease in HLA-B27 transgenic rats.21,22

Hypotheses for the Disease Association of HLA-B27 & AS

Since the discovery of the association between HLA-B27 and AS, many hypotheses have been proposed to explain this association, some of which were short lived. Currently, there are four major hypotheses, which are introduced here. A detailed discussion of this topic and the data supporting or opposing these hypotheses is beyond the scope of this article, and the reader is referred to recent comprehensive reviews on this subject.23-26

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOther Rheumatic Conditions Tagged with:Ankylosing SpondylitisHLA-B27

Related Articles

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Biophoto Associates / Science Source

    A Stiff Man: A Case Study in Ankylosing Spondylitis

    July 12, 2017

    First Appearances I watched the old man, his back painfully bent, shuffle toward the scale. A blocky rigidity draped over him. His feet seemed stuck to the floor. His head hung heavily over his chest. Observing him from the end of the hallway, instead of a face, I saw only a mound of shaggy, matted…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences